Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 1
1(20.0%)
5Total
N/A(4)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02744261Not ApplicableCompleted

Developing Rectal USPE Measures for Suppositories (Project DRUM-S)

Role: collaborator

NCT02102867Not ApplicableCompleted

Developing Rectal USPE Measures

Role: collaborator

NCT01334827Not ApplicableCompleted

A Formative Study to Explore the Sensory Perceptions of Vaginal Product Users

Role: collaborator

NCT03082690Phase 1Completed

ImQuest (IQP) DuoGel Phase 1 Pharmacokinetic Study

Role: collaborator

NCT01716000Not ApplicableCompleted

Optical Imaging and User Perception Study of Vaginal Gel

Role: collaborator

All 5 trials loaded